Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALKS |
---|---|---|
09:32 ET | 16129 | 25.285 |
09:34 ET | 2398 | 25.01 |
09:36 ET | 2020 | 25.01 |
09:38 ET | 1900 | 24.94 |
09:39 ET | 900 | 24.87 |
09:41 ET | 5159 | 24.88 |
09:43 ET | 5656 | 24.77 |
09:45 ET | 3882 | 24.73 |
09:48 ET | 6670 | 24.74 |
09:50 ET | 6900 | 24.78 |
09:52 ET | 4745 | 24.72 |
09:54 ET | 19743 | 24.835 |
09:56 ET | 11769 | 24.76 |
09:57 ET | 1868 | 24.82 |
09:59 ET | 2298 | 24.84 |
10:01 ET | 4539 | 24.84 |
10:03 ET | 9208 | 24.87 |
10:06 ET | 5636 | 24.865 |
10:08 ET | 4061 | 24.879 |
10:10 ET | 1063 | 24.875 |
10:12 ET | 6887 | 24.89 |
10:14 ET | 4636 | 24.88 |
10:15 ET | 3001 | 24.865 |
10:17 ET | 6756 | 24.84 |
10:19 ET | 4389 | 24.825 |
10:21 ET | 4519 | 24.8 |
10:24 ET | 2530 | 24.8 |
10:26 ET | 14383 | 24.755 |
10:28 ET | 5039 | 24.815 |
10:30 ET | 3052 | 24.805 |
10:32 ET | 3231 | 24.82 |
10:33 ET | 1300 | 24.83 |
10:35 ET | 10060 | 24.86 |
10:37 ET | 6571 | 24.83 |
10:39 ET | 1800 | 24.82 |
10:42 ET | 10501 | 24.805 |
10:44 ET | 3190 | 24.84 |
10:46 ET | 9861 | 24.88 |
10:48 ET | 4412 | 24.855 |
10:50 ET | 5196 | 24.855 |
10:51 ET | 5840 | 24.84 |
10:53 ET | 4715 | 24.835 |
10:55 ET | 9597 | 24.79 |
10:57 ET | 4201 | 24.815 |
11:00 ET | 1986 | 24.825 |
11:02 ET | 11255 | 24.75 |
11:04 ET | 2143 | 24.74 |
11:06 ET | 7311 | 24.695 |
11:08 ET | 4180 | 24.69 |
11:09 ET | 4931 | 24.71 |
11:11 ET | 4731 | 24.69 |
11:13 ET | 2624 | 24.65 |
11:15 ET | 2975 | 24.67 |
11:18 ET | 4637 | 24.65 |
11:20 ET | 3413 | 24.64 |
11:22 ET | 2136 | 24.62 |
11:24 ET | 6400 | 24.6 |
11:26 ET | 2500 | 24.605 |
11:27 ET | 10664 | 24.59 |
11:29 ET | 600 | 24.58 |
11:31 ET | 5994 | 24.55 |
11:33 ET | 6052 | 24.5 |
11:36 ET | 2196 | 24.5 |
11:38 ET | 2499 | 24.5 |
11:40 ET | 1299 | 24.49 |
11:42 ET | 900 | 24.49 |
11:44 ET | 3213 | 24.46 |
11:45 ET | 4144 | 24.43 |
11:47 ET | 2822 | 24.42 |
11:49 ET | 3073 | 24.42 |
11:51 ET | 3438 | 24.365 |
11:54 ET | 3743 | 24.355 |
11:56 ET | 2000 | 24.37 |
11:58 ET | 2050 | 24.385 |
12:00 ET | 2589 | 24.36 |
12:02 ET | 1900 | 24.35 |
12:03 ET | 3329 | 24.36 |
12:05 ET | 11042 | 24.37 |
12:07 ET | 2652 | 24.35 |
12:09 ET | 1956 | 24.34 |
12:12 ET | 8183 | 24.32 |
12:14 ET | 4200 | 24.42 |
12:16 ET | 3458 | 24.37 |
12:18 ET | 1650 | 24.35 |
12:20 ET | 3160 | 24.37 |
12:21 ET | 4515 | 24.4 |
12:23 ET | 5412 | 24.39 |
12:25 ET | 2011 | 24.38 |
12:27 ET | 1536 | 24.37 |
12:30 ET | 1660 | 24.36 |
12:32 ET | 3369 | 24.385 |
12:34 ET | 4115 | 24.4 |
12:36 ET | 1552 | 24.38 |
12:38 ET | 1300 | 24.34 |
12:39 ET | 1900 | 24.345 |
12:41 ET | 1650 | 24.35 |
12:43 ET | 800 | 24.35 |
12:45 ET | 800 | 24.355 |
12:48 ET | 1200 | 24.34 |
12:50 ET | 1100 | 24.35 |
12:52 ET | 4397 | 24.415 |
12:54 ET | 4637 | 24.38 |
12:56 ET | 1784 | 24.39 |
12:57 ET | 2481 | 24.42 |
12:59 ET | 1693 | 24.42 |
01:01 ET | 842 | 24.41 |
01:03 ET | 1999 | 24.39 |
01:06 ET | 2444 | 24.3997 |
01:08 ET | 3806 | 24.37 |
01:10 ET | 400 | 24.375 |
01:12 ET | 500 | 24.36 |
01:14 ET | 1100 | 24.36 |
01:15 ET | 2461 | 24.385 |
01:17 ET | 1600 | 24.405 |
01:19 ET | 2700 | 24.38 |
01:21 ET | 5225 | 24.3 |
01:24 ET | 3344 | 24.28 |
01:26 ET | 1600 | 24.24 |
01:28 ET | 5186 | 24.32 |
01:30 ET | 2624 | 24.36 |
01:32 ET | 3522 | 24.37 |
01:33 ET | 3856 | 24.35 |
01:35 ET | 700 | 24.32 |
01:37 ET | 4409 | 24.37 |
01:39 ET | 3794 | 24.37 |
01:42 ET | 2243 | 24.37 |
01:44 ET | 1445 | 24.345 |
01:46 ET | 646 | 24.33 |
01:48 ET | 300 | 24.33 |
01:50 ET | 2300 | 24.335 |
01:51 ET | 6600 | 24.345 |
01:53 ET | 713 | 24.34 |
01:55 ET | 6000 | 24.27 |
01:57 ET | 4827 | 24.3 |
02:00 ET | 100 | 24.31 |
02:02 ET | 1700 | 24.31 |
02:04 ET | 1205 | 24.34 |
02:06 ET | 1140 | 24.34 |
02:08 ET | 2963 | 24.34 |
02:09 ET | 2182 | 24.36 |
02:11 ET | 2195 | 24.37 |
02:13 ET | 626 | 24.37 |
02:15 ET | 4208 | 24.325 |
02:18 ET | 886 | 24.32 |
02:20 ET | 4149 | 24.32 |
02:22 ET | 3250 | 24.35 |
02:24 ET | 1250 | 24.34 |
02:26 ET | 300 | 24.33 |
02:27 ET | 2235 | 24.33 |
02:29 ET | 1548 | 24.33 |
02:31 ET | 9714 | 24.4 |
02:33 ET | 3555 | 24.4 |
02:36 ET | 1500 | 24.405 |
02:38 ET | 3470 | 24.42 |
02:40 ET | 2656 | 24.42 |
02:42 ET | 2552 | 24.42 |
02:44 ET | 1385 | 24.41 |
02:45 ET | 5433 | 24.445 |
02:47 ET | 1454 | 24.41 |
02:49 ET | 2256 | 24.4133 |
02:51 ET | 2830 | 24.4 |
02:54 ET | 2606 | 24.38 |
02:56 ET | 1768 | 24.38 |
02:58 ET | 1856 | 24.38 |
03:00 ET | 2100 | 24.395 |
03:02 ET | 2200 | 24.4 |
03:03 ET | 1900 | 24.4 |
03:05 ET | 1600 | 24.395 |
03:07 ET | 3200 | 24.42 |
03:09 ET | 2728 | 24.44 |
03:12 ET | 1800 | 24.44 |
03:14 ET | 2500 | 24.435 |
03:16 ET | 1146 | 24.425 |
03:18 ET | 5192 | 24.43 |
03:20 ET | 612 | 24.45 |
03:21 ET | 800 | 24.44 |
03:23 ET | 9040 | 24.4 |
03:25 ET | 1260 | 24.41 |
03:27 ET | 5676 | 24.42 |
03:30 ET | 6808 | 24.44 |
03:32 ET | 1422 | 24.44 |
03:34 ET | 5519 | 24.455 |
03:36 ET | 9606 | 24.46 |
03:38 ET | 3524 | 24.42 |
03:39 ET | 4934 | 24.405 |
03:41 ET | 6204 | 24.42 |
03:43 ET | 5724 | 24.435 |
03:45 ET | 8264 | 24.46 |
03:48 ET | 2730 | 24.475 |
03:50 ET | 4451 | 24.47 |
03:52 ET | 22642 | 24.49 |
03:54 ET | 9210 | 24.43 |
03:56 ET | 15709 | 24.47 |
03:57 ET | 21704 | 24.49 |
03:59 ET | 28715 | 24.49 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alkermes Plc | 4.2B | 7.0x | --- |
Exelixis Inc | 6.2B | 32.5x | -21.77% |
PTC Therapeutics Inc | 2.4B | -4.1x | --- |
P3 Health Partners Inc | 199.1M | -1.0x | --- |
Halozyme Therapeutics Inc | 5.5B | 18.1x | --- |
Novavax Inc | 1.8B | -4.2x | --- |
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.2B |
---|---|
Revenue (TTM) | $1.7B |
Shares Outstanding | 169.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.45 |
EPS | $3.50 |
Book Value | $7.20 |
P/E Ratio | 7.0x |
Price/Sales (TTM) | 2.4 |
Price/Cash Flow (TTM) | 6.3x |
Operating Margin | 29.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.